Press Releases Prescient Therapeutics Limited

Equities

Delayed Australian S.E. Other stock markets 07:08:18 26/06/2024 am IST			5-day change	1st Jan Change
0.039 ^AUD	-4.88%		0.00%	-37.10%

25/03	Transcript : Prescient Therapeutics Limited - Special Call
23/02	Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Prescient Therapeutics PTX-100 shows promising results in Phase 1b study	22/05	AQ
Prescient Therapeutics showcases cell therapy data at prestigious ISCT conference	16/23/16	AQ
Prescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100	10/23/10	AQ
Prescient Therapeutics : June 2022 Quarterly Update and Appendix 4C	25/22/25	PU
Prescient Therapeutics : Application for quotation of securities - PTX	22/22/22	PU
Prescient Therapeutics : Application for quotation of securities - PTX	16/22/16	PU
Prescient Therapeutics : March 2022 Quarterly Update and Appendix 4C	29/22/29	PU
Prescient Therapeutics : Application for quotation of securities - PTX	06/22/06	PU
Prescient Therapeutics : Application for quotation of securities - PTX	07/21/07	PU
Prescient Therapeutics : Application for quotation of securities - PTX	30/21/30	PU
Prescient Therapeutics : March 2019 Appendix 4C - Quarterly	24/19/24	PU
Prescient Therapeutics : Notice of General Meeting/Proxy Form	27/19/27	PU
Prescient Therapeutics : Amended Appendix 3B - Rights Issue	27/19/27	PU
Prescient Therapeutics : Letter to Optionholders	25/19/25	PU
Prescient Therapeutics : Letter to Ineligible Shareholders	25/19/25	PU
Prescient Therapeutics : Letter to Eligible Shareholders	25/19/25	PU
Prescient Therapeutics : Appendix 3B - Rights Issue	25/19/25	PU
Prescient Therapeutics : Prospectus	25/19/25	PU
Prescient Therapeutics : Capital Raising Presentation - March 2019	25/19/25	PU
Prescient Therapeutics : Completes Equity Raising to Raise $9.1 Million	25/19/25	PU

No results for this search